Supplementary Figure S5 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers | Synapse
August 15, 2024
Supplementary Figure S5 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers
Key Points
Key points are not available for this paper at this time.
Abstract
Absolute numbers of T cells and IL-18 concentrations during manufacturing
KI fragen
Like
Bookmark
Share
KI fragen
Like
Bookmark
Share
Cite This Study
Fischer‐Riepe et al. (Thu,) studied this question.